 |
|
Web Sightings
Informative and interesting industry news and views from web sites around the globe.
Views On Prescription Drugs And The Pharmaceutical Industry
Prescription drugs play a part in half of all adults’ daily lives, and most agree that these medications have a positive value to society. Majorities say that prescription drugs have had a positive impact on the health and quality of life of Americans in general (78%) and have made a “big difference” in the lives of people with chronic conditions such as heart disease (72%) and cancer (63%).
» Read full story
Labeling Revision for CRESTOR(R) Approved By FDA
WILMINGTON, Del., March 2 -- AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved revisions to the prescribing information for its cholesterol-lowering medication, CRESTOR® (rosuvastatin calcium), based on submissions made by AstraZeneca. The Company is committed to providing the most up-to-date information about the appropriate use of CRESTOR, and will proactively communicate these revisions to healthcare professionals.
» Read full story
FDA Seeks Specific Vioxx Power
WASHINGTON, March 1, 2005 -- (AP) The Food and Drug Administration wants the power to write warning labels for drugs, telling Congress on Tuesday it would help end the haggling with pharmaceutical companies that delayed warnings to Vioxx users about potential heart problems.
» Read full story
A New Look for Optel Vision
Optel Vision is very proud to annouce the new look to its web site. A provider of flexible inspection solutions for new or existing packaging lines, Optel Vision wants to more efficiently serve its first responder customers, existing customers and partners. “We have invested a lot of time in developing our new look because we wanted to promote and demonstrate what sets us apart from our competition, our Inspection, Integration & Service.” said Nancy Houley, Director of Marketing.
» Read full story
For a FREE EVALUATION of your vision inspection application,
call Optel Vision today at 1-866-688 0334 or 1-418-688 0334.
|
|
|
|
|
April 21-27, 2005
Düsseldorf, Germany
Booth 12B9B
April 26-28, 2005
New York
Booth 582
|
|
|
